We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Amryt Pharma Plc | AMYT | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 143.00 | 00:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 143.00 |
| Top Posts |
|---|
Posted at 26/3/2022 15:39 by brummy_git Positive long term clinical data out today wrt AmrytPharma's Oleogel.Indeed most investors seem to have entirely written off this novel EB treatment. So any future approvals from the EMA, UK &/or FDA should provide a major boost to the shares. |
Posted at 01/3/2022 11:50 by papillon Nasdaq investors got it correct around 9 months ago. AMYT obviously overpaid for their latest acquisition. That acquisition was a sign of desperation on the part of Wiley, but UK investors, including me, were slow to acknowledge that fact. An acquisition was the only way AMYT were going to get another drug to add to their existing 2 (and Wiley guessed it) and they had to overpay to acquire it. |
Posted at 28/1/2022 12:55 by brummy_git Likewise, I suspect most investors were half-expecting this to happen. Only 2 months to wait though.Plus including the views of patients who have successfully used the treatment in trials could really help the FDA/EMA decision making processes - when it comes to labelling & application areas. |
Posted at 25/1/2022 15:40 by bermudashorts gnmartinIt's possible to register with Amryt to receive updates. You can register on the Investors section of their website and select the type of alert's you'd like to receive. I've not registered myself so have no idea how reliable the service is but may be worth a try. |
Posted at 09/1/2022 12:34 by ali47fish sold the lot - nobody seems to complain about a company deciding to delist - why not choosing a dual listing/ the board and the directors seem uncaring about the conequences to retail investor - who are you supposed to compain to- i have emailed amryt investor relations |
Posted at 02/12/2021 11:42 by onceaday I asked Interactive Investors and the response I got was that they are still thinking about it... |
Posted at 01/12/2021 09:33 by moorsie2 Bazworth - I meant brave in the context of making an investment initially. Then it is crucial that private investors do not get swayed by vicarious short term volatility and also don't fall into the trap of sunk costs.. |
Posted at 01/12/2021 09:01 by moorsie2 He now has a million or so shares at 1.70 average.He is expecting a very good pay day in time. Investors need patience as well as bravery... |
Posted at 22/11/2021 10:22 by papillon I don't suppose American investors will give a toss, bazworth. Today's news is not surprising. I've been saying ever since they listed on Nasdaq that it's now an American company that's still headquartered in Dublin, no doubt for tax reasons.You've got 2 months to make up your mind what to do. |
Posted at 29/7/2021 00:51 by papillon Actually Adw198 both the LSE & Nasdaq AMYT charts went bearish in May when the falling 50 day EMA went below the already falling 200 day EMA. A so called "Death Cross". I'd already sold all my AMYT shares before that happened. I sold on the day (5th May?) when AMYT announced that takeover. I sold because I looked at the pre market quote for AMYT on Nasdaq and it had dropped like a stone, so I didn't sell because of any charts!!I bought back into AMYT in June because the AMYT Ichimoku chart turned weakly bullish (not strongly bullish). Why? Because I believe in AMYT having held them for years, since FAST relisted as AMYT in May 2016, through thick and thin. You could say my heart overruled my head However that Ichimoku chart soon turned strongly bearish again and I sold all the AMYT shares, I had only recently bought, at a loss and invested the proceeds elsewhere. With the benefit of hindsight it was the correct thing to do. This time my head overruled my heart. Unfortunately the 200 day EMA is still falling as is the 50 day EMA, which has stayed below the 200 day EMA ever since that Bearish Death Cross appeared on the chart. Why did the Nasdaq investors react so badly to that takeover, when the AIM investors had initially pushed up the share price when the deal was announced at noon and before Nasdaq opened? I've no idea, Adw198. Unfortunately AMYT's primary listing is now on Nasdaq and not on AIM these days. AMYT is an Irish company and at least 70% of the AMYT shares are held as ADS's on Nasdaq. Yankee investors call the tune and they obviously didn't like the news of the acquisition. Did they think AMYT had overpaid? Probably. The company taken over is American so they probably know more about the company than we do. I'd like to buy AMYT shares again, but it will be because my head says so and not because of my heart. I've lost lots of money in the past falling in love with a share. I'm not about to do it again. What you do is up to you; you pays your money and you takes your choice. It's your money, just like it's my money. We can spend it how we see fit. At the moment I don't see why I should sell some of my other shares to buy AMYT shares. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
